✦ LIBER ✦

Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases

✍ Scribed by Fu, Yunfeng; Wang, Xinyu; Pan, Zimin; Xie, Xing

Book ID: 125374127
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 91 KB
Volume: 8
Category: Article
ISSN: 2095-0217
DOI: 10.1007/s11684-014-0305-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

nab-Paclitaxel for first-line treatment

nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

✍ O’Shaughnessy, Joyce; Gradishar, William J.; Bhar, Paul; Iglesias, Jose 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 424 KB

Long-term outcomes and prognostic factor

Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment

✍ Kadowaki, Shigenori; Komori, Azusa; Narita, Yukiya; Nitta, Sohei; Yamaguchi, Kaz 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 202 KB

An assessment of age and other factors i

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study

✍ David H Moore; James T Kauderer; Jeffrey Bell; John P Curtin; Linda Van Le 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Prognostic and predictive factors for ou

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

✍ Stefan Sleijfer; Monia Ouali; Martine van Glabbeke; Anders Krarup-Hansen; Sjoerd 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Corrigendum to “An assessment of age and

Corrigendum to “An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Group study” [Gynecol. Oncol. 94 (2004) 368–74]

✍ David H. Moore; James T. Kauderer; Jeffrey Bell; John P. Curtin; Linda Van Le 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Randomized Phase III Study of Erlotinib

Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study

✍ Vergote, I. B.; Jimeno, A.; Joly, F.; Katsaros, D.; Coens, C.; Despierre, E.; Ma 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 189 KB